SCHEMBL13859337

SCHEMBL13859337

COc1ccc(C(NC2=NC(C)(C)C(F)(F)[C@@](C)(c3cc(Nc4cccc(C(F)(F)F)n4)ccc3F)O2)(c2ccccc2)c2ccc(OC)cc2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.34
SYK P43405 2/20 0.33
ACP1 P24666 2/20 0.33
BACE1 P56817 4/20 0.32
ABL1 P00519 2/20 0.32
BCR P11274 2/20 0.32
MAPT P10636 2/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
LMNA P02545 1/20 0.31
RAB9A P51151 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
EGFR P00533 1/20 0.31
ERBB3 P21860 1/20 0.31
IDH2 P48735 2/20 0.31
BACE2 Q9Y5Z0 1/20 0.30
PLK4 O00444 1/20 0.30
DYRK3 O43781 1/20 0.30
MAP4K4 O95819 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13835689 0.89 BACE1 (0.38) APPSYKACP1BACE1MAPT
SCHEMBL13835686 0.89 BACE1 (0.38) APPSYKACP1BACE1MAPT
SCHEMBL13858927 0.85 MAPK14 (0.42) APPACP1BACE1MEN1KMT2A
SCHEMBL13859410 0.83 ACP1 (0.35) ACP1BACE1MAPTKDM4EMEN1
SCHEMBL13859243 0.83 MAPK14 (0.38) ACP1BACE1MAPTBACE2
SCHEMBL13859336 0.83 ACP1 (0.40) APPACP1BACE1BACE2
SCHEMBL13859183 0.81 ACP1 (0.33) ACP1BACE1MAPTKDM4ERAB9A
SCHEMBL1980433 0.80 BACE1 (0.33) BACE1MAPT
SCHEMBL13859465 0.80 BACE1 (0.41) BACE1BACE2
SCHEMBL13859496 0.78 BACE2 (0.40) BACE1IDH2BACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2709992-A1 1,3-OXAZINES AS BACE1 AND/OR BACE2 INHIBITORS F. Hoffmann-La Roche AG (CH) 2014-03-26 EP disclosed
WO-2012156284-A1 1,3-OXAZINES AS BACE1 AND/OR BACE2 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2012-11-22 WO disclosed